Oncostatin M expression is functionally connected to neutrophils in the early inflammatory phase of skin repair: Implications for normal and diabetes-impaired wounds

Journal of Investigative Dermatology

Volumn 126, Issue 3, 2006, Pages 628-637

  Goren, Itamar ^a   Kämpfer, Heiko ^a   Müller, Elke ^a   Schiefelbein, Dana ^a   Pfeilschifter, Josef ^a   Frank, Stefan ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; ONCOSTATIN M;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FIBROBLAST; KERATINOCYTE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; SKIN INJURY; TISSUE REPAIR;

ANIMALS; CYTOKINES; DIABETES MELLITUS; FEMALE; INFLAMMATION; INTERLEUKIN-1; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; NEUTROPHILS; ONCOSTATIN M; RECEPTORS, CYTOKINE; RECEPTORS, ONCOSTATIN M; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 32844461435     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700136     Document Type: Article

References (35)

1. Brown TJ, Lioubin MN, Marquardt H (1987) Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells. J Immunol 139:2977-83
2. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-9
3. Clark RAF (1996) Wound repair: overview and general considerations. In: The molecular and cellular biology of wound repair (Clark RAF, ed.), New York and London: Plenum Press, 3-50
4. Coleman DL (1978) Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14:141-8
5. DiPietro LA (1995) Wound healing: the role of the macrophage and other immune cells. Shock 4:233-40
6. Faffe DS, Flynt L, Mellema M, Whitehead TR, Bourgeois K, Panettieri RA Jr et al. (2005) Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1beta. Am J Physiol Lung Cell Mol Physiol 288:L1040-8
7. Frank S, Stallmeyer B, Kämpfer H, Kolb N, Pfeilschifter J (1999) Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. FASEB J 13:2002-14
8. Frank S, Stallmeyer B, Kämpfer H, Kolb N, Pfeilschifter J (2000) Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair. J Clin Invest 106:501-9
9. Goren I, Kämpfer H, Podda M, Pfeilschifter J, Frank S (2003) Leptin and wound inflammation in diabetic ob/ob mice. Differential regulation of neutrophil and macrophage influx and a potential role for the scab as a sink for inflammatory cells and mediators. Diabetes 52:2821-32
10. Grenier A, Dehoux M, Boutten A, Arce-Vicioso M, Durand G, Gougerot-Pocidalo MA et al. (1999) Oncostatin M production and regulation by human polymorphonuclear neutrophils. Blood 93:1413-21
11. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F (2003) Principles of interleukin (IL)-6-type cytokine signalling and ist regulation. Biochem J 374:1-20
12. Hübner G, Brauchle M, Smola H, Madlener M, Fässler R, Werner S (1996) Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine 8:548-56
13. Hurst SM, McLoughlin RM, Monslow J, Owens S, Morgan L, Fuller GM et al. (2002) Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells. J Immunol 169:5244-51
14. Ihn H, Tamaki K (2000) Oncostatin M stimulates the growth of dermal fibroblasts via a mitogen-activated protein kinase-dependent pathway. J Immunol 165:2149-55
15. Jeffcoate WJ, Harding KG (2003) Diabetic foot ulcers. Lancet 361:1545-51
16. Kämpfer H, Kahlina U, Mühl H, Pfeilschifter J, Frank S (1999) Counterregulation of interleukin-18 mRNA and protein expression during cutaneous wound repair in mice. J Invest Dermatol 113:369-74
17. Kerfoot SM, Raharjo E, Ho M, Kaur J, Seriom S, McCafferty DM et al. (2001) Exclusive neutrophil recruitment with oncostatin M in a human system. Am J Pathol 159:1531-9
18. Lindberg RA, Juan TSC, Welcher AA, Sun Y, Cupples R, Guthrie B et al. (1998) Cloning and characterization of a specific receptor for mouse oncostatin M. Mol Cell Biol 18:3357-67
19. Loots MA, Lamme EN, Zeegelaar J, Mekkes JR, Bos JD, Middelloop E (1998) Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 111:850-7
20. Malik N, Kallestad JC, Gunderson NL, Austin SD, Neubauer MC, Ochs V et al. (1989) Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M. Mol Cell Biol 9:2847-53
21. Martin P (1997) Wound healing-aiming for perfect skin repair. Science 276:75-81
22. Modur V, Feldhaus MJ, Weyrich AS, Jicha DL, Prescott SM, Zimmerman GA et al. (1997) Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression and inflammatory cytokines and adhesion molecules. J Clin Invest 100:158-68
23. Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park LS et al. (1996) Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem 271:32635-43
24. Repovic P, Fears CY, Gladson CL, Benveniste EN (2003) Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells. Oncogene 22:8117-24
25. Rosner K, Ross C, Karlsmark T, Petersen AA, Gottrup F, Vejlsgard GL (1995) Immunohistochemical characterization of the cutaneous cellular infiltrate in different areas of chronic leg ulcers. APMIS 103:293-9
26. Singer AJ, Clark RAF (1999) Cutaneous wound healing. N Engl J Med 341:738-46
27. Stallmeyer B, Kämpfer H, Kolb N, Pfeilschifter J, Frank S (1999) The function of nitric oxide in wound repair: inhibition of inducible nitric oxide-synthase severely impairs wound reepithelialization. J Invest Dermatol 113:1090-8
28. Tanaka M, Miyajima A (2003) Oncostatin M, a multifunctional cytokine. Rev Physiol Biochem Pharmacol 149:39-52
29. Tanaka M, Hara T, Copeland NG, Gilbert DJ, Jenkins NA, Miyajima A (1999) Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor β subunit. Blood 93:804-15
30. Thakur ML, Li J, Chandy B, John EK, Gibbons G (1996) Transient neutropenia: neutrophil distribution and replacement. J Nucl Med 37:489-94
31. Vasse M, Pourtau J, Trochon V, Muraine M, Vannier JP, Lu H et al. (1999) Oncostatin M induces angiogenesis in vitro and in vivo. Arterioscler Thromb Vasc Biol 19:1835-42
32. Wallace PM, MacMaster JF, Rouleau KA, Brown JT, Loy JK, Donaldson KL et al. (1999) Regulation of inflammatory responses by oncostatin M. J Immunol 162:5547-55
33. Werner S, Grose R (2004) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83:835-70
34. Wetzler C, Kämpfer H, Stallmeyer B, Pfeilschifter J, Frank S (2000) Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 115:245-53
35. Zarling JM, Shoyab M, Marquardt H, Hanson MB, Lioubin MN, Todaro GJ (1986) Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. Proc Natl Acad Sci USA 83:9739-43